TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens.
Villanueva-Lizama LE, Cruz-Chan JV, Versteeg L, Teh-Poot CF, Hoffman K, Kendricks A, Keegan B, Pollet J, Gusovsky F, Hotez PJ, Bottazzi ME, Jones KM.
Villanueva-Lizama LE, et al. Among authors: cruz chan jv.
Parasite Immunol. 2020 Oct;42(10):e12769. doi: 10.1111/pim.12769. Epub 2020 Jul 12.
Parasite Immunol. 2020.
PMID: 32592180